Gordon J. Fehr - Net Worth and Insider Trading

Gordon J. Fehr Net Worth

The estimated net worth of Gordon J. Fehr is at least $325,507 dollars as of 2024-11-13. Gordon J. Fehr is the Director of Merrimack Pharmaceuticals Inc and owns about 21,514 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $325,507. Details can be seen in Gordon J. Fehr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gordon J. Fehr has not made any transactions after 2015-04-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gordon J. Fehr

To

Gordon J. Fehr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gordon J. Fehr owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .

Click here to see the complete history of Gordon J. Fehr’s form 4 insider trades.

Insider Ownership Summary of Gordon J. Fehr

Ticker Comapny Transaction Date Type of Owner
MACK Merrimack Pharmaceuticals Inc 2015-04-13 director

Gordon J. Fehr Latest Holdings Summary

Gordon J. Fehr currently owns a total of 1 stock. Gordon J. Fehr owns 21,514 shares of Merrimack Pharmaceuticals Inc (MACK) as of April 13, 2015, with a value of $325,507.

Latest Holdings of Gordon J. Fehr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MACK Merrimack Pharmaceuticals Inc 2015-04-13 21,514 15.13 325,507

Holding Weightings of Gordon J. Fehr


Gordon J. Fehr Form 4 Trading Tracker

According to the SEC Form 4 filings, Gordon J. Fehr has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the sale of 2,000 shares on April 13, 2015, which brought Gordon J. Fehr around $260,000.

Insider Trading History of Gordon J. Fehr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gordon J. Fehr Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gordon J. Fehr Ownership Network

Ownership Network List of Gordon J. Fehr

No Data

Ownership Network Relation of Gordon J. Fehr

Insider Network Chart

Gordon J. Fehr Owned Company Details

What does Merrimack Pharmaceuticals Inc do?

Who are the key executives at Merrimack Pharmaceuticals Inc?

Gordon J. Fehr is the director of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .

Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary

Over the past 18 months, Gordon J. Fehr made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 446,418 shares made by Eric Andersen , and a net purchase of 4,000 shares made by Gary L Crocker .

In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 450,418 shares were bought by its insiders, resulting in a net purchase of 450,418 shares.

Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Merrimack Pharmaceuticals Inc Insider Transactions

No Available Data

Gordon J. Fehr Mailing Address

Above is the net worth, insider trading, and ownership report for Gordon J. Fehr. You might contact Gordon J. Fehr via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.